Select your language

Article

G&L appoints Kevin Webb as Chief Growth Officer

Posted on the 16th August 2024

Kevin Webb Website Two

G&L Healthcare Advisors has announced the appointment of Kevin Webb as Chief Growth Officer.

With over three decades of experience in the pharmaceutical industry, Kevin brings a wealth of knowledge and leadership that will be instrumental in driving G&L’s growth initiatives.

Stephen Loughrey, CEO of G&L Healthcare Advisors, commented:

“We are thrilled to welcome Kevin to the G&L team.

“His understanding of the Regulatory Marketplace on a global basis combined with the many deep relationships he has developed will be of tremendous benefit as we continue to expand our market presence and achieve our strategic growth goals.”

Kevin’s career includes eleven years as Chief Operating Officer at Pharmalink, as well as senior roles at Pfizer and Wyeth.

His expertise in spearheading innovative strategies, fostering strong customer relationships, and engaging with regulatory authorities has consistently delivered results throughout his career.

Speaking about his appointment, Kevin said:

“I am excited to join G&L at this pivotal time in the company’s growth journey.

“I look forward to collaborating closely with the team to drive growth initiatives, enhance acquisition strategies, and explore new market opportunities, all while ensuring we continue to build on G&L’s strong regulatory foundation.”

In his new role, Kevin will report directly to the CEO and serve as a member of the G&L Board of Directors and Executive Committee. His leadership will be vital as G&L rapidly expands its commercial capabilities to complement its established expertise in regulatory affairs.

Ready to reach your potential?

Discover how G&L can help you do business better

Contact Us